Development of transgenic T lymphocytes to break down the immunosuppressive tumor microenvironment and its functional analysis
Project/Area Number |
15K09497
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Hematology
|
Research Institution | Nagoya University |
Principal Investigator |
|
Research Collaborator |
OKUNO Shingo
JULAMANEE Jakrawadee
MIYAO Kotaro
SAKEMURA Reona
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | キメラ抗原レセプター / 遺伝子導入T細胞療法 / CD8陽性細胞 / Tリンパ球 / 腫瘍微小環境 / CD8陽性 |
Outline of Final Research Achievements |
Based on the amino acid sequence information of the antibody against the molecule PD-L1 thought to be expressed on tumor cells in order that tumor cells escape from immune cells, a single-chain antibody binding to PD-L1 was prepared. We further created a novel molecule with CD28 or 4-1BB or both as a part of domain. When this antibody was stained by fluorescent-labeled PD-L1 molecule, it was found that it stained well, indicating that it binds well to the antigen. This gene was transfected into T lymphocytes and its function was examined in vitro and in vivo in mice. On the other hand, we tried to knock out CTLA-4 molecule, which is expressed after activation of T cells and supposedly acts suppressively on self.
|
Report
(4 results)
Research Products
(57 results)
-
[Journal Article] MonoMAC syndrome patient developing myelodysplastic syndrome following persistent EBV infection2018
Author(s)
Yamamoto H, Hattori H, Takagi E, Morishita T, Ishikawa Y, Terakura S, Nishida T, Ito Y, Murata M, Kiyoi H.
-
Journal Title
Rinsho Ketsueki
Volume: 59
Issue: 3
Pages: 315-322
DOI
NAID
ISSN
0485-1439, 1882-0824
Related Report
Peer Reviewed
-
[Journal Article] Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.2017
Author(s)
Terakura S, Wake A, Inamoto Y, Murata M, Sakai R, Yamaguchi T, Takahashi S, Uchida N, Onishi Y, Ohashi K, Ozawa Y, Kanamori H, Yamaguchi H, Fukuda T, Ichinohe T, Takanashi M, Atsuta Y, Teshima T.
-
Journal Title
Bone Marrow Transplant
Volume: 52
Issue: 3
Pages: 423-430
DOI
Related Report
Peer Reviewed
-
[Journal Article] Impact of T-cell chimerism on relapse after cord blood transplantation for hematological malignancies: Nagoya Blood and Marrow Transplantation Group study2017
Author(s)
Yokohata E, Kuwatsuka Y, Ohashi H, Terakura S, Kawashima N, Seto A, Kurahashi S, Ozawa Y, Goto T, Imahashi N, Nishida T, Miyao K, Sakemura R, Kato T, Sawa M, Kohno A, Sao H, Iida H, Kiyoi H, Naoe T, Miyamura K, Murata M
-
Journal Title
Bone Marrow Transplant.
Volume: in press
Issue: 4
Pages: 612-614
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia2017
Author(s)
Terakura S, Kuwatsuka Y, Yamasaki S, Wake A, Kanda J, Inamoto Y, Mizuta S, Yamaguchi T, Uchida N, Kouzai Y, Aotsuka N, Ogawa H, Kanamori H, Nishiwaki K, Miyakoshi S, Onizuka M, Amano I, Fukuda T, Ichinohe T, Atsuta Y, Murata M, Teshima T
-
Journal Title
Bone Marrow Transplant
Volume: 52
Issue: 9
Pages: 1261-1267
DOI
NAID
Related Report
Peer Reviewed
-
-
[Journal Article] Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.2017
Author(s)
Tawara I, Kageyama S, Miyahara Y, Fujiwara H, Nishida T, Akatsuka Y, Ikeda H, Tanimoto K, Terakura S, Murata M, Inaguma Y, Masuya M, Inoue N, Kidokoro T, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Naoe T, Emi N, Yasukawa M, Katayama N, Shiku H.
-
Journal Title
Blood
Volume: 130
Issue: 18
Pages: 1985-1994
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] The activated conformation of integrin β7 as a target for multiple myeloma-specific chimeric antigen receptor T cell therapy.2017
Author(s)
Hosen N, Matsunaga Y, Hasegawa K, Matsuno H, Nakamura Y, Makita M, Watanabe K, Yoshida M, Satoh K, Morimoto S, Fujiki F, Nakajima H, Nakata J, Nishida S, Tsuboi A, Oka Y, Manabe M, Ichihara H, Aoyama Y, Mugitani A, Nakao T, Hino M, Uchibori R, Ozawa K, Baba Y, et al.
-
Journal Title
Nat. Med.
Volume: 23
Issue: 12
Pages: 1436-1443
DOI
Related Report
Peer Reviewed
-
[Journal Article] Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study).2017
Author(s)
Nishiwaki S, Sugiura I, Miyata Y, Saito S, Sawa M, Nishida T, Miyamura K, Kuwatsuka Y, Kohno A, Yuge M, Kasai M, Iida H, Kurahashi S, Osaki M, Goto T, Terakura S, Murata M, Nishikawa H, Kiyoi H
-
Journal Title
Medicine
Volume: 96
Issue: 52
Pages: e9568-e9568
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.2017
Author(s)
Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M.
-
Journal Title
Leukemia
Volume: 31(3)
Issue: 3
Pages: 663-668
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Malignant lymphoma with cardiac involvement2017
Author(s)
Terakura S, Onji M, Iriyama C, Goto T, Ushijima Y, Shimada K, Ishikawa Y, Nishida T, Hayakawa F, Murata M, Kiyoi H
-
Journal Title
Rinsho Ketsueki
Volume: 58
Issue: 3
Pages: 239-242
DOI
NAID
ISSN
0485-1439, 1882-0824
Related Report
Peer Reviewed
-
[Journal Article] Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy2016
Author(s)
Goto T, Nishida T, Takagi E, Miyao K, Koyama D, Sakemura R, Hanajiri R, Watanabe K, Imahashi N, Terakura S, Murata M, Kiyoi H
-
Journal Title
J Immunother.
Volume: 39
Issue: 8
Pages: 306-315
DOI
Related Report
Peer Reviewed
-
[Journal Article] A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration2016
Author(s)
Sakemura R, Terakura S, Watanabe K, Julamanee J, Takagi E, Miyao K, Koyama D, Goto T, Hanajiri R, Nishida T, Murata M, Kiyoi H
-
Journal Title
Cancer Immunol Res.
Volume: 4
Issue: 8
Pages: 658-668
DOI
Related Report
Peer Reviewed
-
[Journal Article] Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.2016
Author(s)
Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura
-
Journal Title
Biol Blood Marrow Transplant.
Volume: 22
Issue: 2
Pages: 330-338
DOI
Related Report
Peer Reviewed
-
[Journal Article] Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection.2015
Author(s)
Hanajiri R, Murata M, Sugimoto K, Murase M, Sakemura R, Goto T, Watanabe K, Imahashi N, Terakura S, Ohashi H, Akatsuka Y, Kurahashi S, Miyamura K, Kiyoi H, Nishida T, Naoe T
-
Journal Title
Bone Marrow Transplant.
Volume: 50
Issue: 9
Pages: 1187-1194
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse.2015
Author(s)
Imahashi N, Ohashi H, Terakura S, Miyao K, Sakemura R, Kato T, Sawa M, Yokohata E, Kurahashi S, Ozawa Y, Nishida T, Kiyoi H, Watamoto K, Kohno A, Kasai M, Kato C, Iida H, Naoe T, Miyamura K, Murata M
-
Journal Title
Ann Hematol.
Volume: 94
Issue: 7
Pages: 1139-1148
DOI
Related Report
Peer Reviewed
-
-
[Presentation] Genetically-Modified CD3zeta Improves Proliferation and Persistence of Antigen-specific CTLs.2018
Author(s)
Miyao K, Terakura S, Okuno S, Jakrawadee J, Watanabe K, Hamana H, Kishi H, Sakemura R, Koyama D, Goto T, Nishida T, Murata M, Kiyoi H.
Organizer
第40回日本造血細胞移植学会総会
Related Report
-
-
-
-
-
-
[Presentation] Intrabone single unit cord blood transplantation for hematological malignancies.2017
Author(s)
Murata M, Maeda Y, Masuko M, Fukuhara N, Nishida T, Terakura S, Ishikawa Y, Tanimoto M, Shibasaki Y, Suzuki R, Kodera Y, Kiyoi H, Naoe T
Organizer
第76回日本癌学会学術総会
Related Report
-
-
-
-
[Presentation] The synergistic T-cell signal by CD79A/CD40 costimulatory endodomain enhances CD19 chimeric antigen receptor T-cell proliferation and survival.2017
Author(s)
Julamanee J, Terakura S, Sakemura R, Miyao K, Okuno S, Kamoshita S, Takagi E, Koyama D, Goto T, Hanajiri R, Nishida T, Murata M, Kiyoi H.
Organizer
The 59th annual meeting of the American Society of Hematology
Related Report
Int'l Joint Research
-
[Presentation] Quantitative assessment of TCR repertoire and allo-reactivity of human acute GVHD tissue-infiltrating T cells.2017
Author(s)
Koyama D, Murata M, Hanajiri R, Okuno S, Kamoshita S, Takagi E, Julamanee J, Miyao K, Sakemura R, Goto T, Terakura S, Nishida T, Kiyoi H.
Organizer
The 59th annual meeting of the American Society of Hematology
Related Report
Int'l Joint Research
-
-
[Presentation] Intrabone transplantation of a single cord blood unit using non-irradiated reduced-intensity conditioning.2016
Author(s)
Murata M, Maeda Y, Masuko M, Onishi Y, Endo T, Terakura S, Ishikawa Y, Iriyama C, Ushijima Y, Goto T, Fujii N, Tanimoto M, Kobayashi H, Shibasaki Y, Fukuhara N, Inamoto Y, Suzuki R, Matsushita T, Kodera Y, Kiyoi H, Naoe T, Nishida T.
Organizer
58th ASH Annual Meeting and Exposition
Place of Presentation
San Diego (USA)
Year and Date
2016-12-03
Related Report
Int'l Joint Research
-
[Presentation] Phase 1 clinical trial of adoptive immunotherapy for acute myelogenous leukemia and myelodysplastic syndrome, using gene-modified autologous lymphocytes expressing WT1-specific T-cell receptor.2016
Author(s)
Tanimoto K, Fujiwara H, Tawara I, Masuya M, Kageyama S, Nishida T, Murata M, Terakura S, Akatsuka Y, Ikeda H, Miyahara Y, Nukaya I, Takesako K, Emi N, Katayama N, Shiku H, Yasukawa M.
Organizer
58th ASH Annual Meeting and Exposition
Place of Presentation
San Diego (USA)
Year and Date
2016-12-03
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Adoptive transfer of WT1-specific TCR gene-transduced lymphocytes in patients with myelodysplastic syndrome and acute myeloid leukemia.2015
Author(s)
Tawara I, Masuya M, Kageyama S, Nishida T, Terakura S, Murata M, Fujiwara H, Akatsuka Y, Ikeda H, Miyahara Y, Tomura D, Nukaya I, Takesako K, Emi N, Yasukawa M, Katayama N, Shiku H.
Organizer
57th ASH Annual Meeting and Exposition
Place of Presentation
Orlando, USA
Year and Date
2015-12-05
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-